Capricor Therapeutics Inc.

In News

Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory - Yahoo Finance

Yahoo Finance - Dec 18, 2025

Following Sarepta Woes, Others Look To Unlock the Next Chapter in DMD Treatment - BioSpace

BioSpace - Feb 09, 2026

Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court (CAPR) - Seeking Alpha

Seeking Alpha - Dec 03, 2025

Capricor Therapeutics (NASDAQ: CAPR) Phase 3 HOPE-3 Meets Skeletal, Cardiac Goals in DMD - Stock Titan

Stock Titan - Dec 03, 2025

Capricor Therapeutics Announces Positive Topline Results - GlobeNewswire

GlobeNewswire - Dec 03, 2025

Capricor soars on positive results for Duchenne cell therapy - BioPharma Dive

BioPharma Dive - Dec 03, 2025

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 6.7% - Here's Why - MarketBeat

MarketBeat - Jan 28, 2026

Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy - Fierce Biotech

Fierce Biotech - Dec 03, 2025

Capricor Therapeutics Inc. Provides Regulatory Update on Deramiocel BLA Submission Following FDA Request for HOPE-3 Clinical Study Report - Quiver Quantitative

Quiver Quantitative - Jan 20, 2026

Capricor shares sink as US FDA declines to approve cell therapy - Reuters

Reuters - Jul 11, 2025

Capricor Therapeutics (CAPR) Valuation After Positive Phase 3 HOPE-3 Results for DMD Therapy Deramiocel - Yahoo Finance

Yahoo Finance - Dec 03, 2025

Capricor Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewswire

GlobeNewswire - Dec 04, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment